These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16805013)

  • 1. Thais protest US-Thai FTA talks.
    Franklin T
    HIV AIDS Policy Law Rev; 2006 Apr; 11(1):26-7. PubMed ID: 16805013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on access to medicines from TRIPS-Plus: a case study of Thai-US FTA.
    Kessomboon N; Limpananont J; Kulsomboon V; Maleewong U; Eksaengsri A; Paothong P
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):667-77. PubMed ID: 20578557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thailand: successful challenge to invalid patent claim on antiretrovirals.
    Kaplan K
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):60-1. PubMed ID: 14740606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam.
    Moir HVJ; Tenni B; Gleeson D; Lopert R
    Glob Public Health; 2018 Apr; 13(4):400-413. PubMed ID: 27841097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.
    Rosenberg ST
    Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 100th HIV/AIDS antiretroviral drug approved by PEPFAR.
    AIDS Patient Care STDS; 2009 Nov; 23(11):988-9. PubMed ID: 19938372
    [No Abstract]   [Full Text] [Related]  

  • 7. The potential impact of the Comprehensive and Progressive Agreement for Prans-Pacific Partnership on Thailand's hepatitis C treatment program.
    Tenni B; Lexchin J; Akaleephan C; Kittitrakul C; Gleeson D
    Global Health; 2024 Jun; 20(1):46. PubMed ID: 38867208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of low cost AIDS drugs to continue in Brazil.
    Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899
    [No Abstract]   [Full Text] [Related]  

  • 9. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.
    Ford N; Wilson D; Costa Chaves G; Lotrowska M; Kijtiwatchakul K
    AIDS; 2007 Jul; 21 Suppl 4():S21-9. PubMed ID: 17620749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global trade and access to medicines: AIDS treatments in Thailand.
    Wilson D; Cawthorne P; Ford N; Aongsonwang S
    Lancet; 1999 Nov; 354(9193):1893-5. PubMed ID: 10584741
    [No Abstract]   [Full Text] [Related]  

  • 13. The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to Medicines.
    Townsend B; Gleeson D; Lopert R
    Asia Pac J Public Health; 2016 Nov; 28(8):682-693. PubMed ID: 27920239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extension of market exclusivity and its impact on the accessibility to essential medicines, and drug expense in Thailand: analysis of the effect of TRIPs-Plus proposal.
    Akaleephan C; Wibulpolprasert S; Sakulbumrungsil R; Luangruangrong P; Jitraknathee A; Aeksaengsri A; Udomaksorn S; Tangcharoensathien V; Tantivess S
    Health Policy; 2009 Jul; 91(2):174-82. PubMed ID: 19150741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAFTA will harm HIV care, according to critics. Final agreement helps drug companies, they say.
    AIDS Alert; 2004 Feb; 19(2):17-8. PubMed ID: 15011625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIPS AGREEMENT ARTICLE 31(B): THE NEED FOR REVISION.
    Effingham AM
    Seton Hall Law Rev; 2016; 46(3):883-909. PubMed ID: 27066613
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.
    Venkatesh KK; Mayer KH; Carpenter CC
    Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
    Halliburton M
    Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. . . . and Brazilian AIDS programme threatened by US trade action.
    Int J Epidemiol; 2001 Apr; 30(2):413. PubMed ID: 11369751
    [No Abstract]   [Full Text] [Related]  

  • 20. Thailand's do-it-yourself therapy.
    Cohen J
    Science; 2003 Sep; 301(5640):1662. PubMed ID: 14500957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.